Dental Soft-Tissue Regeneration Market By Product Type, Application, End User, Country, And Region, 2025-2035

(MENAFN- GlobeNewsWire - Nasdaq) The market is rapidly advancing, driven by the increasing prevalence of periodontal diseases and the demand for effective treatment options

Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Dental Soft-tissue Regeneration Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, Country, and Region- Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets's offering.
One of the primary drivers of the Dental Soft-Tissue Regeneration market is the rising prevalence of periodontal diseases, such as gum recession and periodontitis. As these conditions become more widespread globally, there is an increasing demand for effective treatments to regenerate lost gum tissue, restore oral health, and improve aesthetics. Periodontal disease, which affects a significant portion of the population, often leads to the deterioration of gum tissues and can result in tooth loss if left untreated.
The need to address these issues, coupled with the growing awareness of the importance of maintaining healthy gums for overall oral health, is fueling the demand for soft-tissue regeneration procedures. Additionally, the aging population and the rise in dental implant procedures further contribute to this growth, as healthy, regenerated gum tissue is essential for the success and longevity of implants.
Despite the growth of the Dental Soft-Tissue Regeneration market, several challenges persist. One of the primary challenges is the high cost of procedures and materials. Regenerative treatments, including gum grafting, platelet-rich plasma (PRP) therapies, and advanced biomaterials, often involve significant costs.
These costs can be prohibitive for many patients, especially when insurance coverage is limited or unavailable. Additionally, the complexity of the procedures, the need for specialized training, and the requirement for high-quality materials add to the overall expense, making these treatments less accessible to a broader patient base. This financial barrier remains one of the key obstacles to the widespread adoption and growth of soft-tissue regeneration techniques in the dental industry.
The global Dental Soft-Tissue Regeneration market is indeed highly competitive, with numerous prominent players shaping the industry's growth and innovation. Companies like Dentsply Sirona, Geistlich Pharma AG, Institut Straumann AG, Tissue Regenix, Septodont Holding, Regedent AG, Advanced Medical Solutions Group PLC, Regenity, ZimVie Inc., and Henry Schein, Inc. are driving the development of advanced solutions in soft-tissue regeneration.
These companies are investing heavily in research and development, expanding their product portfolios, and forming strategic partnerships to enhance their competitive edge. Their efforts are focused on improving biomaterials, regenerative technologies, and minimally invasive procedures to meet the growing demand for effective soft-tissue restoration.
By offering a wide range of cutting-edge products and addressing the diverse needs of dental professionals and patients, these companies are contributing significantly to the market's evolution. As the demand for personalized and effective soft-tissue regeneration solutions increases, these industry leaders are poised to play a critical role in shaping the future of dental care.
Dental Soft-tissue Regeneration Market Segmentation

Segmentation 1: by Product Type

• Autografts
• Synthetic Biomaterials
• Collagen-Based Membranes
• Others

Segmentation 2: by Application

• Implantology
• Periodontology
• Others

Segmentation 3: by End User

• Dental Hospitals
• DSO's & Independent Clinics
• Academic & Research Institutions

Segmentation 4: by Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

One of the most significant emerging trends in the global Dental Soft-Tissue Regeneration market is the increasing adoption of minimally invasive techniques. Patients and dental professionals are increasingly favoring treatments that involve smaller incisions, shorter recovery times, and less discomfort, which is driving the demand for laser therapy, microsurgical techniques, and biomaterial-based treatments.
These advancements allow for more precise interventions, reduce post-operative complications, and improve patient satisfaction. Moreover, the use of regenerative technologies such as Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), and stem cell therapies is gaining traction, as they offer potential for accelerated healing and tissue regeneration. This shift towards minimally invasive and regenerative treatments is significantly enhancing the effectiveness and appeal of soft-tissue regeneration in dentistry, especially in periodontal care and implantology.

Companies Profiled in the Report

• Dentsply Sirona
• Geistlich Pharma AG
• Institut Straumann AG
• Tissue Regenix
• Septodont Holding
• Regedent AG
• Advanced Medical Solutions Group PLC
• Regenity
• ZimVie Inc.
• Henry Schein, Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN07012026004107003653ID1110568491